Search Contact
AB-Biotics to attend the IPA World Congress + Probiota Americas, the world’s premier probiotics and prebiotics event
20 June 2019

AB-Biotics will actively participate in the IPA World Congress + Probiota Americas organized by NutraIngredients-USA, which will take place in Vancouver, Canada, from June 24th to 26th. The congress is the premier annual event in the prebiotics, probiotics, and microbiota market focused on the pharma and food industries.

AB-Biotics will have a booth along with its main shareholder, the Japanese company Kaneka. Kaneka’s Dr. Fumiki Aoki, Business Development Director de Kaneka Probiotics Division, will be a speaker in the panel “Building consumer trust in prebiotics and probiotics”, while Dra. Meritxell Aguiló, Clinical Research Officer at AB-Biotics, will present two clinical trials.  AB-BIOTICS co-founder and Executive Director Miquel Àngel Bonachera will moderate the round table discussion/lunch titled “Metagenomic approach and clinical substantiation on new probiotic applications”.

Dr. Aoki’s session will discuss how to boost consumer trust in the information regarding the microbiome and its health implications, as well as how the sector can ensure that patients receive and understand the most appropriate information, mainly by guaranteeing that the information comes from reliable sources.

Dra. Aguiló will present two posters: the first, entitled “Demographic and clinical factors influencing the effects of a cholesterol-lowering probiotic,” discusses the efficacy of AB-Life on lowering LDL cholesterol and triglyceride levels. The second, “Probiotic patient characteristics influencing infant colic amelioration under a probiotic treatment,” addresses how AB-Kolicare improves the symptoms of functional gastrointestinal disorders (FGID), mainly infant colic and constipation.

Bonachera’s round table discussion on metagenomics will focus on how current evidence, based on several clinical studies, shows that certain strains can have positive effects in gastrointestinal inflammation, cardiovascular and oral health, and urogenital infections and how metagenomics can contribute to the development of new probiotic strains.

“Our collaboration with Kaneka is essential and strategic for our positioning and growth in the US. We are very in a good momentum”, explained Sergi Audivert, co-Founder and Executive Director at AB-Biotics.

AB Biotics-Kaneka Probiotics is one of the event’s Platinum Sponsors.

 The hashtags and handles for the event are: